{'fraction_non_alphanumeric': 0.02202339986235375, 'fraction_numerical': 0.009635237439779766, 'mean_word_length': 5.609090909090909, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
CHANGES IN THE PHYSICAL AND NEUROPSYCHIATRIC STATUSES OF COVID-19 PATIENTS IN RESPONSE TO REHABILITATION

Annotation: Relevance. Over 60% of patients who have undergone COVID-19 have serious physical and neuropsychiatric functional impairments both in the early and late periods after the acute phase of the disease. Target. The quality-of-life impairment in these patients provides a clear rationale for examining the effectiveness of rehabilitative treatment programs in these patients. Materials and methods. The study involved patients who have undergone COVID-19-associated pneumonia and have persistent disorders of physical neuropsychic status, and in general, deterioration in varying degrees of quality of life. Results.The inclusion of Derinat®, a solution of 15 mg / ml in outpatient medical organizations in the medical support of rehabilitation programs for patients with COVID-19 of varying severity, led to a reduction in the manifestations of physical status impairment; increasing endurance and reducing the recovery period during physical activity; reduction of symptoms of impaired neuropsychic status (disappearance of feelings of fatigue and anxiety),increasing appetite and improving the quality of personal care. Conclusions. Thus, a multidisciplinary approach to restorative treatment using a drug that stimulates regeneration and reparation causes positive changes in the quality of life of patients who have undergone COVID-19.